Stock listing
2H51 Stock Price, News, Filings & Events — Ocugen, Inc.
Selected listing: 2H51 · GETTEX · EUR · DE
This page tracks Ocugen, Inc.'s 2H51:GETTEX listing on GETTEX in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 2H51:GETTEX. 2H51:GETTEX is the stock-level entry point for investors researching Ocugen, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
- Ticker
- 2H51:GETTEX
- Asset type
- Stock
- Market cap
- $471.4M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- GETTEX
- Currency
- EUR
Ocugen, Inc. 2H51:GETTEX stock context
This page tracks Ocugen, Inc.'s 2H51:GETTEX listing on GETTEX in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 2H51:GETTEX. 2H51:GETTEX is the stock-level entry point for investors researching Ocugen, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
Latest news from Ocugen, Inc.
Ocugen to Participate in Upcoming September Investor and Industry Conferences
August 25, 2026
Ocugen to Participate in Upcoming August Investor Conferences
July 31, 2026
Ocugen Announces that the U.S. Food and Drug Administration Has Granted OCU410 Regenerative Medicine Advanced Therapy (RMAT) Designation ...
July 29, 2026
Ocugen to Host Conference Call on Thursday, August 6 at 8:30 A.M. ET to Discuss Business Updates and Second Quarter 2026 Financial Results
July 28, 2026
Ocugen, Inc. Announces Binding Term Sheet with Roots Pharmaceutical to License OCU400 Modifier Gene Therapy for Retinitis Pigmentosa in t...
July 13, 2026
Research Ocugen, Inc.
Ocugen, Inc. investor report
Review AI stock analysis and investor report context for 2H51:GETTEX.
Ocugen, Inc. company profile
View the public company page for Ocugen, Inc. on 6ix.
Ocugen, Inc. news
Read company news and market updates connected to Ocugen, Inc..
Ocugen, Inc. investor events
Find investor webinars, events, and replay context for Ocugen, Inc..
Alternate listings
OCGN:NASDAQ
US · USD
Alternate listing for Ocugen, Inc.; the primary context on this page is 2H51:GETTEX.
2H51:TRADEGATE
DE · EUR
Alternate listing for Ocugen, Inc.; the primary context on this page is 2H51:GETTEX.
A2PSZH:LSX
DE · EUR
Alternate listing for Ocugen, Inc.; the primary context on this page is 2H51:GETTEX.
OCGN:BMV
MX · MXN
Alternate listing for Ocugen, Inc.; the primary context on this page is 2H51:GETTEX.
A2PSZH:LS
DE · EUR
Alternate listing for Ocugen, Inc.; the primary context on this page is 2H51:GETTEX.
2H51:FWB
DE · EUR
Alternate listing for Ocugen, Inc.; the primary context on this page is 2H51:GETTEX.
2H51:SWB
DE · EUR
Alternate listing for Ocugen, Inc.; the primary context on this page is 2H51:GETTEX.
2H51:MUN
DE · EUR
Alternate listing for Ocugen, Inc.; the primary context on this page is 2H51:GETTEX.
2H51:DUS
DE · EUR
Alternate listing for Ocugen, Inc.; the primary context on this page is 2H51:GETTEX.
OCGN:BOATS
US · USD
Alternate listing for Ocugen, Inc.; the primary context on this page is 2H51:GETTEX.
OCGN:BIVA
MX · MXN
Alternate listing for Ocugen, Inc.; the primary context on this page is 2H51:GETTEX.
2H51:HAM
DE · EUR
Alternate listing for Ocugen, Inc.; the primary context on this page is 2H51:GETTEX.